Premium
Strontium brachytherapy in conjunctival melanoma
Author(s) -
MISSOTTEN G,
DE KEIZER RJW,
SPILEERS W,
BLANK L
Publication year - 2011
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2011.4262.x
Subject(s) - brachytherapy , medicine , strontium , sclera , surgery , melanoma , radiation therapy , physics , cancer research , nuclear physics
Purpose To describe the experience, the indications, the outcome, complications and prognosis of strontium brachytherapy in bulbar conjunctival melanoma. Methods 46 with conjunctival melanoma, treated with strontium brachytherapy in Leuven, Leiden or Amsterdam, were revised. Clinical indications, visual outcome, prognosis and complications were registered. Results In 38 patients 6x10 Gy was used, with 2 recurrences and 1 scleral melting. In 7 cases 6x5,9 Gy was used with 4 recurrences. In 3 cases a second strontium brachytherapy application was needed. Although there were in almost all cases transient dry eye symptoms, no major anterior segment problems were seen. With the exception of 1 scleral melting,in a patient where also a previous extended surgery was done with excision of sclera. Conclusion Strontium brachytherapy is a safe treatment for conjunctival melanomas, when a dosis of 60 Gy is used. It gives rarely complications.